Home
About
Product
Product Center
R&D pipeline
Platform
Blog
Company News
Notice
Industry News
Talent
Contact
Contact Information
Online message
News Center
Sinorda Pharmaceutical presented four posters at APDW for discussion.
Category:
Time:2023-12-06 09:41
Sinorda Pharmaceutical attended APDW and presented research data on a new drug, X842 Lipid Capsules, spanning from Phase I to Phase III clinical trials.
Sinorda Pharma's Shenzhen roadshow ranked among the top three.
Time:2023-11-28 09:46
Recently, Sinorda Pharma participated in the "BioFunding Easy Enterprise Financing Roadshow," placing third at the third stop held in the Pearl River Delta region.
Sinorda Pharmaceutical and Sanyou Biotech sign a strategic cooperation agreement to deeply advance innovative drug research and development.
Time:2023-08-18 09:49
Sinorda Pharmaceutical has signed a strategic cooperation agreement with Sanyou Biopharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") on an innovative bispecific antibody drug project.
Sinorda Pharmaceutical has formed a strategic partnership with Boteng Biotech to accelerate the development of cell therapy drugs for solid tumors.
Time:2022-04-22 09:54
On April 22, 2022, Sinorda Pharmaceutical entered into a strategic partnership with Suzhou Boteng Biopharmaceutical Co., Ltd. The two companies will establish a long-term, comprehensive strategic alliance focusing on cell therapy drug development, as well as the construction of cell and gene therapy R&D and manufacturing platforms, and international regulatory submissions.